Hot Topics: Marijuana and Medical Marijuana: Social Aspects

"Proponents of legalizing recreational marijuana say it will add billions to the economy, create hundreds of thousands of jobs, free up scarce police resources, and stop the huge racial disparities in marijuana enforcement. They contend that regulating marijuana will lower street crime, take business away from the drug cartels, and make marijuana use safer through required testing, labeling, and child-proof packaging. They say marijuana is less harmful than alcohol, and that adults should have a right to use it if they wish.

Opponents of legalizing recreational marijuana say it will increase teen use and lead to more medical emergencies including traffic deaths from driving while high. They contend that revenue from legalization falls far short of the costs in increased hospital visits, addiction treatment, environmental damage, crime, workplace accidents, and lost productivity. They say that marijuana use harms the user physically and mentally, and that its use should be strongly discouraged, not legalized. "

"Pew Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping the world. We conduct public opinion polling, demographic research, content analysis and other data-driven social science research. We do not take policy positions."

University of California's Center for Medicinal Cannabis Research (CMCR). The purpose of the Center is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions.

U.S. National Institute on Drug Abuse.

"The Conversation is a nonprofit, independent news organization dedicated to unlocking the knowledge of experts for the public good. We publish trustworthy and informative articles written by academic experts for the general public and edited by our team of journalists."

June 25, 2018

"Over the past several years, FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). As part of these actions, FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Consumers should beware purchasing and using any such products."

Includes transcript and citation.